PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 28, 2025Circulation Cardiovascular Quality and Outcomes13 citationsOpen Access

Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older Adults

View Full Paper
MFMichelle A. FravelMEMichael E. ErnstRWRobyn L. Woods

Key Result

The PREVENT risk calculator demonstrated superior discriminative performance compared to the PCE calculator for predicting ASCVD events in adults aged 65-79 (C statistic 0.793 vs 0.740; P<0.001).

Key Points

  • This research aims to assess the performance of the American Heart Association PREVENT calculator compared to the 2013 Pooled Cohort Equations for predicting ASCVD risk in older adults.
  • Prospective cohort study of adults aged ≥70 years without CVD from Australia and the US.
  • Participants were enrolled in the ASPREE trial from 2010 to 2014, followed up until 2022.
  • Discriminative ability was evaluated using the Harrell C statistic and Cox regression for age groups 65-79 and ≥80 years.
  • Among 15,510 participants aged 65-79 years, PREVENT predicted 1290 ASCVD events while PCE predicted 3102 events; C statistic for PREVENT was 0.793 versus 0.740 for PCE (P<0.001).
  • For 2787 participants aged ≥80 years, PREVENT predicted 350 events while PCE predicted 1067 events; C statistic for PREVENT was 0.854 compared to 0.799 (P<0.001).
  • PREVENT demonstrated superior discriminative performance compared to PCE in both age groups.

Study Design

Type

Cohort (n=18,297)

Multicenter

Yes

Structured PICO

Does the PREVENT risk calculator improve 10-year ASCVD risk prediction compared to the PCE calculator in older adults without CVD?

P
Population
18,297 adults without CVD from Australia and the United States aged ≥70 years (≥65 years for US minorities) enrolled in the ASPREE trial.
I
Intervention
American Heart Association Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator
C
Comparator
2013 Pooled Cohort Equation (PCE) calculator
O
Outcome
Discriminative ability (Harell C statistic) and calibration for predicting 10-year ASCVD risksurrogate

The PREVENT risk calculator provides superior discrimination and calibration for predicting ASCVD events in older adults compared to the older Pooled Cohort Equations.

Main Result

Effect estimate: C statistic 0.793 vs 0.740 (65-79 years) and 0.854 vs 0.799 (≥80 years)

p-value: p=<0.001

Abstract

BACKGROUND: The ability of the American Heart Association Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator to accurately assign 10-year atherosclerotic cardiovascular disease (ASCVD) risk in older individuals, including those aged ≥80 years, is unknown. This study compares PREVENT with the 2013 Pooled Cohort Equation (PCE) calculator for predicting 10-year ASCVD risk in a large cohort of older adults. METHODS: This was a prospective cohort study of adults without CVD from Australia and the United States aged ≥70 years (≥65 years, if US minorities). They were enrolled from 2010 to 2014 in the ASPREE trial (Aspirin in Reducing Events in the Elderly), a 5-year randomized trial of low-dose aspirin in community-dwelling older adults with posttrial observational follow-up extending to 2022. ASCVD events were adjudicated by expert panels. The discriminative ability of the 2 risk calculators was assessed by Harell C statistic following Cox regression in the 65- to 79-year age group and >80-year age group, separately. For calibration, predicted event numbers were calculated using PREVENT and PCE, scaled for the actual length of follow-up, and compared with the number of observed events in-trial and during extended follow-up. RESULTS: Among the 15 510 participants aged 65 to 79 years (median age, 73.2 years; 56.1% women), 1084 ASCVD events occurred (median follow-up, 8.3 years); PCE predicted 3102 events while PREVENT predicted 1290 events. For the 2787 participants ≥80 years (median age, 82.6 years; 59.2% women), 355 ASCVD events occurred (median follow-up, 7.4 years); PCE predicted 1067 events while PREVENT predicted 350 events. PREVENT showed superior discriminative performance compared with PCE (PREVENT versus PCE, C statistic, 0.793 versus 0.740; P <0.001 in participants aged 65 –79 years; 0.854 versus 0.799; P <0.001 in those aged ≥80 years). CONCLUSIONS: The PREVENT risk calculator is superior to the PCE calculator in predicting ASCVD events in older adults from the United States and Australia, including those aged ≥80 years. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01038583. URL: https://www.isrctn.com ; Unique identifier: ISRCTN83772183.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fravel et al. (2025) conducted a cohort in Adults without cardiovascular disease (n=18,297). PREVENT calculator vs. 2013 Pooled Cohort Equation (PCE) calculator was evaluated on Discriminative ability (Harell C statistic) for ASCVD events (C statistic 0.793 vs 0.740 (65-79 years) and 0.854 vs 0.799 (≥80 years), p=<0.001). The PREVENT risk calculator demonstrated superior discriminative performance compared to the PCE calculator for predicting ASCVD events in adults aged 65-79 (C statistic 0.793 vs 0.740; P<0.001).

synapsesocial.com/papers/6a1cb0020f544c23831d8d6bhttps://doi.org/10.1161/circoutcomes.124.011719
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly2018 · 1,144 citations
  2. 2Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations2024 · 97 citations
  3. 3Predicted Cardiovascular Risk by the PREVENT Equations in US Adults With Stage 1 Hypertension2024 · 20 citations
  4. 4Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk2018 · 289 citations
  5. 52018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines2019 · 6,252 citations